Your browser doesn't support javascript.
Evaluation of Strategies to Fight COVID-19: The French Paradigm.
Giraud-Gatineau, Audrey; Gautret, Philippe; Colson, Philippe; Chaudet, Hervé; Raoult, Didier.
  • Giraud-Gatineau A; IHU Méditerranée Infection, 13005 Marseille, France.
  • Gautret P; Institut de Recherche pour le Développement (IRD), Assistance Publique-Hôpitaux de Marseille (AP-HM), Service de Santé des Armées (SSA), Vecteurs-Infections Tropicales et Méditerranéennes (VITROME), Aix Marseille University, 13005 Marseille, France.
  • Colson P; French Armed Forces Center for Epidemiology and Public Health (CESPA), Service de Santé des Armées (SSA), 13014 Marseille, France.
  • Chaudet H; Assistance Publique-Hôpitaux de Marseille (AP-HM), 13005 Marseille, France.
  • Raoult D; IHU Méditerranée Infection, 13005 Marseille, France.
J Clin Med ; 10(13)2021 Jun 30.
Article in English | MEDLINE | ID: covidwho-1403797
ABSTRACT
(1)

Background:

We collected COVID-19 mortality data and the age distribution of the deceased in France and other European countries, as well as specifically in the cities of Paris and Marseille, and compared them. (2)

Methods:

Data on mortality related to COVID-19 and the associated age distribution were collected from government institutions in various European countries. In France, data were obtained from INSEE and Santé Publique France. All-cause mortality was also examined in order to study potential excess mortality using EuroMOMO. The Marseille data came from the epidemiological surveillance system. (3)

Results:

France is one of the European countries most impacted by COVID-19. Its proportion of deaths in people under 60 years of age is higher (6.5%) than that of Italy (4.6%) or Spain (4.7%). Excess mortality (5% more deaths) was also observed. Ile-de-France and the Grand-Est are the two French regions with the highest mortality. The proportion of deaths in the under-60 age group was considerable in Ile-de-France (9.9% vs. 4.5% in the Southern region). There are significantly higher numbers of patients hospitalized, in intensive care and deceased in Paris than in Marseille. (4)

Conclusions:

No patient management, i.e., from screening to diagnosis, including biological assessment and clinical examination, likely explains the high mortality associated with COVID-19.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Experimental Studies / Prognostic study Language: English Year: 2021 Document Type: Article Affiliation country: Jcm10132942

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Experimental Studies / Prognostic study Language: English Year: 2021 Document Type: Article Affiliation country: Jcm10132942